|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||35.40 - 36.11|
|52-week range||35.40 - 66.28|
|Beta (5Y monthly)||0.16|
|PE ratio (TTM)||395.56|
|Earnings date||23 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||56.56|
Galapagos NV (GLPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Galapagos NV (GLPG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Here is how Galapagos NV (GLPG) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.